FDA grants approval for Abbott’s ALK Gene Test
Abbott (NYSE: ABT) announced that a new molecular diagnostic test has been approved by the U.S. Food and Drug Administration
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine